The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Diabetes drug canagliflozin protects patients from heart ailments, stroke, high blood pressure and kidney failure; Helps in weight loss

Tuesday, 13 June, 2017
International Business Times